IntegraGen
ALINT | XPAR
Overview
Corporate Details
- ISIN(s):
- FR0010908723
- LEI:
- 969500CQD8K0BUIGDH55
- Country:
- France
- Address:
- 5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
- Website:
- https://integragen.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
IntegraGen is an OncoDNA Group company specializing in the genomics of cancer and genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in genomic services which has been operating sequencing platforms for research institutes of excellence. IntegraGen's mission is to translate molecular research into clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting-edge genomic services to academic researchers and life sciences companies based on the company's technological expertise and scientific know-how.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-29 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 351.8 KB | |
| 2025-04-29 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 356.4 KB | |
| 2025-01-15 18:44 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 214.4 KB | |
| 2025-01-15 18:44 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 215.6 KB | |
| 2024-10-17 18:29 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 343.2 KB | |
| 2024-10-17 18:29 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 398.7 KB | |
| 2024-07-18 18:44 |
Earnings Release
Inside Information / Other news releases
|
English | 270.7 KB | |
| 2024-07-18 18:44 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 268.3 KB | |
| 2024-04-18 18:00 |
Inside Information Statement
Inside Information / News release on accounts, results
|
English | 372.7 KB | |
| 2024-04-18 18:00 |
Inside Information Statement
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 419.4 KB | |
| 2024-01-16 17:45 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 307.9 KB | |
| 2024-01-16 17:45 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 269.3 KB | |
| 2023-10-19 18:15 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 332.6 KB | |
| 2023-07-13 07:30 |
Inside Information Statement
Inside Information / Other news releases
|
English | 204.7 KB | |
| 2023-04-24 18:00 |
Inside Information Statement
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 330.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |